2026 Affiliate Program Conference (Pharmacist Track)

Friday, March 13, 2026, 8:00 AM - 4:00 PM, Marlo Thomas Center

1. Recognize the benefits of collaboration in the care of pediatric hematology and oncology patients
2. Describe advances in supportive care therapy for patients with hematologic and oncologic conditions
3. Describe advanced in laboratory testing that may impact the treatment of hematologic and oncologic conditions

Reminders for Claiming CPE Credit:

• Attendance must be recorded via text message by the end of day on 3/13/26

• Completion of a test & evaluation in your CloudCME profile are required to be awarded credit

• DO NOT use the 'claim credit' button on the CloudCME website (this is configured only for CME credit)

If you have questions or concerns, please contact [email protected]

The St. Jude Children’s Research Hospital Department of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  

St. Jude Children’s Research Hospital designates this for a maximum of 2.7 CPE hours (0.1 CEU per 1 CPE hour).

Pharmacy continuing education credit will be available to all participants who attend, text attendance, and complete a program assessment and evaluation. Credits will be uploaded and viewable on-line at www.napb.net within approximately two weeks following the date of the presentation.  Participants should contact the CPE staff if credit does not appear within 4 weeks of a program.

 

Mitigation of Relevant Financial Relationships

St Jude Children's Research Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (ie, companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.